Number of the records: 1  

Discovery of the first dual inhibitor of the 5-lipoxygenase-activating protein and soluble epoxide hydrolase using pharmacophore-based virtual screening

  1. 1.
    0474823 - ÚEB 2018 RIV GB eng J - Journal Article
    Temml, V. - Garscha, U. - Romp, E. - Schubert, G. - Gerstmeier, J. - Kutil, Zsófia - Matuszczak, B. - Waltenberger, B. - Stuppner, H. - Werz, O. - Schuster, D.
    Discovery of the first dual inhibitor of the 5-lipoxygenase-activating protein and soluble epoxide hydrolase using pharmacophore-based virtual screening.
    Scientific Reports. Roč. 7, FEB 20 (2017), č. článku 42751. ISSN 2045-2322. E-ISSN 2045-2322
    Institutional support: RVO:61389030
    Keywords : activating protein * drug discovery * leukotriene biosynthesis * inflammatory diseases * conformer generation * arachidonic-acid * flap * challenges * asthma * risk
    OECD category: Physiology (including cytology)
    Impact factor: 4.122, year: 2017
    Permanent Link: http://hdl.handle.net/11104/0271773
    FileDownloadSizeCommentaryVersionAccess
    2017_Temml_SCIENTIFIC REPORTS_42751.pdf2759.2 KBOtheropen-access
     
     
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.